HIV/AIDS is often perceived as a death sentence and remains one of the most dreaded viruses worldwide.
Many individuals contract this perilous illness through sexual contact with HIV-positive partners, perpetuating the pervasive fear surrounding the virus. Tragically, some are born with the disease as it is transmitted from their parents.
To combat the virus, HIV-positive individuals must adhere to a daily regimen of Antiretroviral medications (ARVs) to extend their lives and hinder the progression of the infection.
The encouraging news is that a vaccine has been developed, specifically intended for those already living with HIV. This groundbreaking vaccine will be administered twice a year, significantly reducing the frequency of ARV consumption compared to previous standards.
The development of this vaccine can be attributed to the diligent efforts of the American Food and Drug Administration (FDA), which explored innovative strategies for combatting HIV/AIDS.